Home/Filings/4/0001209191-20-045494
4//SEC Filing

Sze Randoll 4

Accession 0001209191-20-045494

CIK 0001300699other

Filed

Aug 5, 8:00 PM ET

Accepted

Aug 6, 4:54 PM ET

Size

11.7 KB

Accession

0001209191-20-045494

Insider Transaction Report

Form 4
Period: 2020-06-05
Sze Randoll
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-06-05+75,00075,000 total
    Exercise: $12.45Exp: 2030-06-05Common Stock (75,000 underlying)
Holdings
  • Common Stock

    5,000
  • Stock Option (Right to Buy)

    Exercise: $17.09Exp: 2028-08-20Common Stock (90,000 underlying)
    90,000
  • Stock Option (Right to Buy)

    Exercise: $17.77Exp: 2027-10-03Common Stock (28,000 underlying)
    28,000
  • Stock Option (Right to Buy)

    Exercise: $13.17Exp: 2029-02-28Common Stock (60,000 underlying)
    60,000
  • Stock Option (Right to Buy)

    Exercise: $17.30Exp: 2028-03-27Common Stock (10,000 underlying)
    10,000
Footnotes (6)
  • [F1]This option vests in four equal annual installments beginning on August 20, 2019.
  • [F2]This option vests in four equal annual installments beginning on October 3, 2018.
  • [F3]This option vests in four equal annual installments beginning on March 27, 2019.
  • [F4]This option vests in four equal annual installments beginning on February 28, 2020.
  • [F5]These options were granted contingent on receiving shareholder approval of the Amended and Restated 2017 Omnibus Incentive Plan, which approval was received on June 5, 2020.
  • [F6]This option vests in four equal annual installments beginning on June 5, 2021.

Issuer

Athenex, Inc.

CIK 0001300699

Entity typeother

Related Parties

1
  • filerCIK 0001751011

Filing Metadata

Form type
4
Filed
Aug 5, 8:00 PM ET
Accepted
Aug 6, 4:54 PM ET
Size
11.7 KB